CPD
$9.95
The HMPS I trial: Adverse events in patients and negligence
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The HOPE Trial: Ramipril reduces cardiovascular events in high-risk patients with normal ejection fractions
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The HOT trial: Diastolic blood pressure targets in hypertension
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The JUPITER: Rosuvastatin reduces the risk of major cardiovascular events in healthy patients
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The LRC-CPPT 1: Cholestyramine and coronary heart disease
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The MERIT-HF Trial: Metoprolol reduces mortality in patients with symptomatic heart failure
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The MIRACL Trial: Atorvastatin reduces recurrent ischemia after acute coronary syndrome
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The RALES Trial: Spironolactone reduces mortality in heart failure patients
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The REMATCH Trial: Left ventricular assist devices reduce mortality in heart failure
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The SAVE Trial: Captopril reduces mortality after acute myocardial infarction
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The SOLVD Trial: Enalapril reduces mortality in heart failure with reduced ejection fraction
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The UKPDS: Reducing diabetes-related morbidity and mortality
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The Val-HeFT Trial: Valsartan reduces morbidity in chronic heart failure
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The V-HeFT I: Hydralazine and isosorbide dinitrate reduce mortality in heart failure
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD
$9.95
The V-HeFT II Trial: Enalapril reduces mortality in heart failure when compared to hydralazine and isosorbide
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
Free
Use of Remote Speech Analysis to Predict Worsening Heart Failure Events in Ambulatory Heart Failure Patients
This is a Module from the Course
By Professor William T. Abraham, M.D. on behalf of co-authors and The CordioHearO™Community Study Group
Expected time:15 minutes
